Drugs / NaCl
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03870646 | Apr 2019 → Oct 2020 | critical illness polyneuropathy, tracheal disorder | Hospital Universitario Virgen de la Arrixaca | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NaCl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03870646 ↗ |
| Route | Inhaled | “nebulized Hypertonic saline of NaCl (7%) in combination with hyaluronic acid” NCT03870646 ↗ |